Home
University of Bergen
The Department of Biomedicine

News archive for The Department of Biomedicine

Elderly man shopping with facemask
COVID-19 and Vitamin D (14.12.2020)
Gro Vatne Røsland is a researcher at the Department of Biomedicine and has written a popular scientific article summarizing current research regarding Vitamin D-intake and infectious diseases.
Sikresonen
Work environment award for our SAFETY ZONE (11.12.2020)
The SAFETY ZONE is a bright yellow wall featuring equipment you may need in case of an emergency. The wall has raised the level of laboratory safety at the Department and has therefore been awarded this year's work environment award from the Faculty of Medicine.
Ine Kjosås (venstre) og Emilie Seljesth (høyre) under MOL231 posterpresentasjon, våren 2019.
From MOL231 Project to Published Article (23.11.2020)
Ine and Emilie were attending a project course priming them for lab work. They ended up co-developing a method to quality control a cell model which is used by thousands of researchers worldwide.
Ordfører Marte Mjøs Pedersen gir Rolf Reed en koronavennleg albuehilsen etter utdelinga av fortenestemedaljen
Royal award for academic achievement (12.11.2020)
Professor Rolf Reed from the Department of Biomedicine was awarded the King's Medal of Merit.
Halberg lab
The Cancer Society Gives Millions to Nils Halberg (12.11.2020)
Nils Halberg from the Department of Biomedicine will receive almost 8 million kroner from the Norwegian Cancer Society for his research on obesity and pancreatic cancer.
Halberg lab
The Cancer Society Gives Millions to Nils Halberg (12.11.2020)
Nils Halberg from the Department of Biomedicine will receive almost 8 million kroner from the Norwegian Cancer Society for his research on obesity and pancreatic cancer.
Andrea Gras Navarro
Yet another best PhD prize for the Brain Tumour Immunology and Therapy Group! (21.10.2020)
Best PhD prize 2019 – Andrea Gras Navarro - “Towards Natural Killer cellular Immunotherapy for glioblastoma. KIR-HLA ligand interaction and proteasome inhibitors to potentiate efficacy"
frits_thorsen_med_kolleger_i_kina
Received Research Funding in China (06.10.2020)
Professor Frits Thorsen and his research group at the ChiNor Research Laboratory has newly received a significant funding of 550 000 RMB over four years (equivalent to 200 000 NOK per year), from the China´s National Natural Science Foundation, for their ongoing research on exosome-derived miRNAs in brain metastases.
PFN2 co-operates with NAA80 to acetylate actin
The cell motility regulator NAA80 is assisted by Profilin 2 (25.09.2020)
Actin is modified by N-terminal acetylation which regulates its role in steering cellular architecture and cell motility. Now the machinery performing this acetylation is uncovered.
The NAA10 Asn101Lys variant disrupts the NAA10-NAA15 (NatA) complex and thereby the ability of this complex to carry out protein N-terminal acetylation.
Novel gene variants linked to developmental delay and hemihypertrophy (25.09.2020)
Several variants of the NAA10 gene have been found in patients suffering from developmental delay and hemihypertrophy. NAA10 steers the most common protein modification in humans: N-terminal acetylation.
Brain cancer is different from other cancers (25.09.2020)
Rolf Bjerkvig of the group for translational cancer research has given a lecture at the Norwegian science festival "Forskningsdagene" in 2020. You can watch a video at the Norwegian Cancer Union.
bilde_til_sak_om_utstilling_hovedbilde.jpg
Pioneers of molecular biology (16.09.2020)
Few people know the researchers Agnar Nygaard and Kjell Kleppe, but in the 1960s they were part of the world elite that laid the foundation for today's COVID-19 tests. Two permanent exhibitions about the pioneers have now been opened.
Pictures of Monica Hellesvik, Hanne Øye, Henriette Aksnes
Research from home (16.09.2020)
On Thursday 12th of March, the University of Bergen was shut down on short notice. Employees and students left their study and workplaces, worried about the recently declared pandemic situation and how the next weeks and months would be like.
How was the service?
Feedback in Nor-Openscreen survey (02.06.2020)
BiSS is growing as a core facility, and we are quite happy that our users are satisfied.
Pills spilling
Drug from BergenBio in clinical trial against COVID-19 (15.05.2020)
UiB spin-off biotech company BergenBio announced that their drug bemcentinib is frast-tracked in a phase-II clinical trial as a potential treatment against COVID-19.
Toronto skyline
Diversity Our Strength (15.05.2020)
Have you ever considered doing a research stay abroad to broaden your scientific horizon? Postdoctor Sylvia Varland recently returned from a 2-year research stay at University of Toronto. Learn more about her scientific adventure and cultural experiences.
Structure of actin, profilin and NAA80
Mechanism of a cell motility regulator (07.04.2020)
Actin is the most abundant protein in human cells and is involved in numerous functions including steering cellular architecture, cell motility and cell division. Recently, UiB researchers identified NAA80 as a long-sought actin regulator. Now, the structure of NAA80 bound to actin and profilin reveals its mechanism of action.
Research_Exosomes_results
Exosome-derived miRNAs in the pre-metastatic niche formation in melanoma brain metastases (02.04.2020)
Exosomes released from the primary tumour into circulation have been documented to promote pre-metastatic niche formation. We have identified a miRNA in exosomes from melanoma brain metastases that can play a vital role in this process. Knock-down (KD) of this miRNA results in an inhibition of brain metastatic growth. We are in the process of identifying potential drugs inhibiting the expression... Read more

Pages